Growing Up With Autism Spectrum Disorder: Understanding Labels, Advocacy, And Neurodiversity
DOI:
https://doi.org/10.69980/ajpr.v28i5.579Abstract
This article explores the psychosocial challenges faced by individuals on the autism spectrum and their caregivers. It examines how social narratives, diagnostic labels, and advocacy efforts shape their lived experiences. Drawing on in-depth interviews with autistic self-advocates, caregivers, and practitioners, the study investigates the evolving discourse around autism, the shift from deficit-based models to neurodiversity frameworks, and the importance of inclusive practices. Findings suggest that while awareness has grown, societal stigma, ableism, and inconsistency in practitioner approaches continue to challenge autistic individuals' rights to self- definition and inclusion.
References
1. American Psychological Association. (2003). Diagnostic and Statistical Manual of Mental DIsorders (5th Ed). Washington, DC: Author.
2. Arboleda-Forez, J., & Stuart, H. (2012). From Sin to Science: Fighting Stigmatisation of Mental Illness. CanJPsychiatry, 457-463.
3. Ary, D., Jacobs, L. C., Sorensen, C., & Razavieh, A. (2010). Introduction to Research In Education (8th ed.). Wadsworth Cengage Learning.
4. Bagatell, N. (2010, March 11). From Cure to Community: Transforming Notions of Autism. Journal of the Society for Psychological Anthropology, 38(1), 35-55. doi:https://doi.org/ 10.1111/j.1548-1352.2009.01080.x
5. Bhatla, M., Shalu, C., Bhatla, J., & Kaloiya, S. G. (2015, April ). Faith Healers in Modern Psychiatric Practice: Results of a 4 years Study. Delhi Psychiatry Journal, 18(1), 48-53.
6. Broderick, A. A., & Ne'eman, A. (2008, December 16). Autism as metaphor: narrative and counter‐narrative. INternational Jouranal of Inclusive Education, 12(5-6), 459-476. doi:https://doi.org/ 10.1080/13603110802377490
7. Canadian Mental Health Association. (2014). Myths about Mental Health . Cascio, M. A. (2012, June). Neurodiversity: Autism Pride Among Mothers of Children with Autism Spectrum Disorders. Intellectual and Developmental Disabilities, 50(3), 273-283.
8. Centre for Disease Control and Prevention. (2018, April 9). Developmental Disabilities. Retrieved from CDC: https://www.cdc.gov/ ncbddd/ developmental disabilities/features/ birthdefects-dd-keyfindings.html
9. Crisp, H. A., Gelder, G. M., Susannah, R., Meltzer, I. H., & Rowlands, J. O. (n.d.). Stigmatizatiion of People with Mental Illness. The British Journal of Psychiatry, 4-7.
10. Daley, T. C., Singhal, N., & Krishnamurthy, V. (2013, September). Ethical Considerations in Conducting Research on Autism Spectrum Disorders in Low and Middle Income Countries. Journal of Autism and Developmental Disorders, 43(9), 2002-2014.
11. Desai, M. U., Divan, G., Wertz, F. J., & Patel, V. (2012, June 21). The discovery of autism: Indian parents’ experiences of caring for their child with an autism spectrum disorder. Transcultural Psychiatry, 49(3-4), 613-637.
12. DeStefano, F., & Thompson, W. W. (2014, January 9). MMR Vaccine and Autism: An Update of the Scientific Evidence. Expert Review of Vaccines, 3(1), 19-22.
13. Doshi-Velez, F., Avillach, P., Palmer, N., Bousvaros, A., Ge, Y., Fox, K., . . . Kohane, I. (2015, October 1). Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders. Oxford Acadamic, 21(10), 2281-2288. Retrieved from https://doi.org/10.1097/MIB. 0000000000000502
14. Draaisma, D. (2009). Stereotypes of autism. Philosophical Transactions of the Royal Society B: Biological Sciences, 1475-1480.
15. Eggertson, L. (2010, February 4). Lancet retracts 12-year-old article linking autism to MMR vaccines. CMAJ, 182(4), 199-200.
16. Farrington, C. P., Miller, E., & Taylor, B. (2001, June 14). MMR and autism: further evidence against a causal association. (Elsevier, Ed.) Vaccine, 19(27), 3632-3635.
17. Fine, H. J. (1979). Cues and Clues to Differentia; DIagnoses in Childhod Autism. Psychotherapy: Theory, Research and Practice, 16(4).
18. Fudenberg, H. H. (1996). Dialysable lymphocyte extract (DLyE) in infantile onset autism: A pilot study. Biotherapy, 9(1-3), 143-147.
19. Ghai, S., Sharma, N., Sharma, S., & Kaur, H. (2013, October ). Shame and Stigma of Mental Illness. Delhi Psychiatry Journal, 16(2), 293-301.
20. Grandjean, P., & Landrigan, P. J. (2014, March). Neurobehavioural effects of developmental toxicity. The Lancet, 13(3), 330-338.
21. Gurrieri, P., & Neri, G. (2009, October 22). Defective oxytocin function: a clue to understanding the cause of autism? BMC Medicine, 7(1), 63.
22. Hehir, T. (2019, March). Confronting Ableism. Educational Leadership, 64(5), 8-14. Retrieved from https://www.learntechlib. org/p/ 99685/
23. Hughes, C., & Leekam, S. (2004, October 7). What are the Links Between Theory of Mind and Social Relations? Review, Reflections and New Directions for Studies of Typical and Atypical Development. Social Development, 13(4), 590-619. doi:https://doi. org/10.1111/j.1467-9507.2004.00285.x
24. Hultman, C. M., Sandin, S., Levine, S. Z., Lichtenstein, P., & Reichenberg, A. (2010, November 30). Advancing paternal age and risk of autism: new evidence from a population- based study and a meta-analysis of epidemiological studies. Molecular Psychiatry, 16(12), 1203-1212.
25. Hviid, A., Stellfeld, M., Wohlfahert, J., & Melbye, M. (2003). Association Between Thimerosal-Containing Vaccine and Autism. JAMA, 260(13), 1763-1766.
26. Ilango, P., & Nirmala, V. (1992, January). Burden of Care of Chronic Mental Illness. The Indian Journal of Social Work, 23-28.
27. Institute of Medicine (US) Immunization Safety Review Committee. (2004).
28. Immunization safety review: vaccines and autism. US: Immunization Safety Review: Vaccines and Autism. National Academies Press .
29. Jaarsma, P., & Welin , S. (2012, March). Autism as a Natural Human Variation: Reflections on the Claims of the Neurodiversity Movemen. Health Care Analysis, 20(1), 20-30.
30. Kite, D. M., Gullifer, J., & Tyson, G. A. (2013, July). Views on the Diagnostic Labels of Autismand Asperger’s Disorder and the Proposed Ch anges in the DSM. Journal of Autism and Developmental Disorders, 43(7), 1692-1700.
31. Landrigan, P. J., Lambertini, L., & Birnbaum, L. S. (2012, July 1). A Research Strategy to Discover the Environmental Causes of Autism and Neurodevelopmental Disabilities. Retrieved from Environmental Health Perspectives: https://doi. org/10.1289/ ehp.1104285
32. Malhotra, S., & Ashis, V. (2005). Pervasive developmental disorders: Indian scene. Journal of Indian Association for child and adolescent mental health, 1(5).
33. Osgood, R. (2006). Language, Labels, and Lingering (Re)considerations: The Evolution and Fuction of Terminology in Special Education. Philosophical Studies in Education, 37, 135-145.
34. Pasman, J. (n.d.). The Consequences of Labelling Mental Illness on the Self-Concept: A Review of the Literature and Future Directions. Social Cosmos.
35. Sen, B., Singh, S., S, S., Chatterjee, S., Ahmed, S., Ghosh, S., & R, U. (2010, March 10). Family‐based studies indicate association of Engrailed 2 gene with autism in an Indian population. Genes, Brain and Behavior, 9(2), 248-255.
36. Singh, A., Matoo, K., & Grover, S. (2016, April-June). Stigma Associated with Mental Illness:Conceptual Issues and Focus on Stigma Perceived by Patients with Schizophrenia and Their Caregivers. Indian Journal of Social Psychiatry, 32(2), 134-142.
37. Smith, L., Foley, P. F., & Chaney, M. P. (2011, December 23). Addressing Classism, Ableism, and Heterosexism in Counselor Education. Journal of Counseling and Development, 86(3), 303-309.
38. Tărlungeanu, D. C., Deliu, E., Dotter, C. P., Kara, M., Janiesch, P. C., Scalise, M., . . . Novarino,G. (2016, December 1). Impaired Amino Acid Transp ort at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder. Cell, 167(6), 1481-1494.
39. Vijayalaksmi, B., & Ramana, K. (n.d.). Mental Illness and FAmily Response: A Study of Coping Techniques. Indian Journal of Social Work, 629-635.
40. Wakefield, A. J. (1999). MMR Vaccine and Autism. The Lancet, 354(9182), 949-950. Weitlauf, A. S., McPheeters, M. L., Peters, B., Sathe, N., Travis, R., Aiello, R., . . .Warren, Z. (2014, August). Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update [Internet]. Retrieved from Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. (Comparative Effectiveness Review, No. 137.):
https://www.ncbi.nlm.nih.gov/books/NBK241444/
41. Williams, K., Tuck, M., Helmer, M., Bartak, L., Mellis, C., & Peat, J. K. (2007, October 10). Diagnostic labelling of autism spectrum disorders in NSW. Journal of Paediatrics and Child Health, 44(3), 108-113. doi:https://doi.org/ 10.1111/j.1440-1754.2007.01232.x
42. World Health Organization. (2017, April 4). Autism Spectrum Disorder. Retrieved from World Health Organization: https://www.who.int/ news-room/fact-sheets/detail/autism- spectrum- Disorders
43. Zeffiro, T. A., & Mottron, L. (2013). The Level and Nature of Autistic Intelligence III: Inspection Time. Journal of Abnormal Psychology, 295-301. 59Zelazo, P. D., & Muller, U. (2002). Executive function in typical and atypical development. Blackwell handbook of childhood cognitive development, 445-469.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.